Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.4.1.2 (
glutamate dehydrogenase
)
4,380
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The neuropathological findings in a patient with antemortem diagnosis of
olivopontocerebellar atrophy
(
OPCA
) and reduced leucocytic
glutamate dehydrogenase
(
GDH
) activity included cerebellar cortical degeneration, most marked in the superior vermis, mild atrophy of the pons and the inferior olivary nucleus, marked reduction of anterior horn cells at all levels and gliosis in both lateral columns.
GDH
activities and their thermolability in "soluble" and "particulate" fractions in the cerebral cortex, cerebellar hemisphere and vermis were not significantly different from the values in two control brains. GDH mRNA in the patient's brain was not altered in size or amount.
...
PMID:Multiple system degeneration with glutamate dehydrogenase deficiency: pathology and biochemistry. 170 75
The activity of total and heat-stable
glutamate dehydrogenase
(
GDH
) in lymphocytes increased with aging in 40 control subjects (p less than 0.001). The total
GDH
activity was lower in patients with
olivopontocerebellar atrophy
(
OPCA
), motor neuron disease, Parkinson's disease or Alzheimer's disease than in age-matched control subjects, but not in patients with nondegenerative neurological diseases. The decrease in heat-stable
GDH
activity was observed in patients with
OPCA
, Parkinson's disease or Alzheimer's disease, but heat-labile
GDH
was decreased only in patients with
OPCA
.
...
PMID:Lymphocyte glutamate dehydrogenase activity in normal aging and neurological diseases. 258 34
The activity of
glutamate dehydrogenase
, the enzyme of glutamate degradation, was measured in platelets of 27 healthy controls and 85 patients with different degenerative cerebellar and/or basal ganglia disorders. A group of 7 patients was selected with slowly progressive multiple-system atrophy, in whom a clinical diagnosis of
olivopontocerebellar atrophy
appeared tenable, with decreased activity of
glutamate dehydrogenase
(38% of the mean control value). In 4 patients data on inheritance were compatible with the genetic pattern of autosomal recessive inheritance, while 3 patients were sporadic cases. In an effort to define this group of patients more precisely, it is suggested that decreased activity of
glutamate dehydrogenase
induces an increase in extracellular glutamate levels in the central nervous system with subsequent development of excitotoxicity.
...
PMID:Degenerative neurological disorders associated with deficiency of glutamate dehydrogenase. 270 51
The activity of 7 mitochondrial enzymes, fumarase, NAD-malate dehydrogenase (MDH), citrate synthase (CS), valine dehydrogenase (VDH), succinate dehydrogenase (SDH),
glutamate dehydrogenase
(
GDH
), pyruvate dehydrogenase complex (PDHC) has been measured in platelet preparations from patients affected by Friedreich's ataxia (FA), dominant and non-dominant
olivopontocerebellar atrophy
(DOPCA, NDOPCA) and normal individuals. Significant decreases of
GDH
(P less than 0.01), PDHC (P less than 0.01), VDH (P less than 0.05) and SDH (P less than 0.05) activities were observed in FA patients. Significant decreases of
GDH
(P less than 0.01), PDHC (P less than 0.01), VDH (P less than 0.05), SDH (P less than 0.05) and CS (P less than 0.05) activities were Observed in ND-
OPCA
patients, whereas in DOPCA patients only
GDH
activity was significantly (P less than 0.05) decreased. In 8 of 10 patients with FA and in all patients with NDOPCA the activity of one or more of 4 enzymes, i.e.
GDH
, VDH, SDH, PDHC, was lower than the lowest of control values. Four of 6 patients with DOPCA had
GDH
activity lower than the lowest of control values. These results indicate that abnormalities of mitochondrial metabolism is a constant element in hereditary ataxia and suggest that the alteration primary leading to the different types of ataxias should be related to mitochondrial oxidative metabolism, at least at a regulatory level.
...
PMID:Abnormalities of mitochondrial enzymes in hereditary ataxias. 281 70
Leucocyte
glutamate dehydrogenase
(
GDH
) activity was measured in 26 normal control subjects, 20 patients with multiple system atrophy presenting features of either
olivopontocerebellar atrophy
or striatonigral degeneration and in a heterogenous group of 15 patients with spinocerebellar degenerations. A broad range of
GDH
activity was found in all three groups. Low activity failed to correlate with a specific clinical entity. Patients followed to post-mortem examination to date have demonstrated histological features of at least three distinct morbid entities. It is concluded, contrary to earlier reports including the authors', that low leukocyte
GDH
activity does not identify a particular type of multiple system atrophy.
...
PMID:Low leukocyte glutamate dehydrogenase activity does not correlate with a particular type of multiple system atrophy. 322 Dec 18
The activities of brain
glutamate dehydrogenase
and malate dehydrogenase were not statistically different in samples from patients with autosomal dominant
olivopontocerebellar atrophy
or Joseph disease compared with control subject samples. These two enzymes are thus not involved in the pathogenesis of these two separate dominantly inherited diseases.
...
PMID:Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy. 346 19
Evaluation of
glutamate dehydrogenase
(
GDH
) in 12 patients with
olivopontocerebellar atrophy
showed deficiency of the enzyme in the group as well as in each patient. The activity of total
GDH
was 77.7% of that in controls. We also demonstrated two components of this enzyme differentiated by their thermostabilities. The activity of the heat-labile component was remarkably reduced in patients although that of the heat-stable component showed the same magnitude as in controls. These data suggest that
GDH
deficiency is mainly caused by its heat-labile component deficiency, which might be related to the pathogenesis of this disease.
...
PMID:Glutamate dehydrogenase and its isozyme activity in olivopontocerebellar atrophy. 373 37
By neurophysiologic investigations, we evaluated 20 patients with
olivopontocerebellar atrophy
(
OPCA
), comprising 8 with
glutamate dehydrogenase
(
GDH
) deficiency and 12 with normal
GDH
activity. We found sensorimotor, predominantly sensory axonal neuropathy distally in the legs, and peripheral auditory nerve dysfunction (prolonged wave I but normal interpeak latencies in brainstem auditory evoked response) in
GDH
-deficient patients. These findings seem distinctive enough to serve as the electrophysiologic marker for diagnosis and monitoring of treatment and progression of the disease. The pattern-reversal visual and median nerve somatosensory evoked responses did not differ among the patients and controls.
...
PMID:Neurophysiologic study of olivopontocerebellar atrophy with or without glutamate dehydrogenase deficiency. 399 Sep 65
Altered metabolism of neuroexcitatory amino acids has been described in patients with a form of
olivopontocerebellar atrophy
(
OPCA
) associated with
glutamate dehydrogenase
(
GDH
) deficiency. To further investigate the specificity of these results, oral glutamate loading tests were performed in healthy controls, patients with
GDH
deficient
OPCA
as well as patients with non-
GDH
deficient degenerative disorders affecting primarily the function of the cerebellum and/or the basal ganglia. Following oral intake of monosodium glutamate, plasma levels of glutamate, aspartate and taurine increased significantly in controls and similar increases also occurred in patients with non-
GDH
deficient disorders. However, patients with
GDH
-deficient
OPCA
showed much greater elevations in plasma glutamate and aspartate and a rather flat taurine curve.
...
PMID:Oral glutamate loading in disorders with spinocerebellar and extrapyramidal involvement: effect on plasma glutamate, aspartate and taurine. 614 89
Deficiency of glutamate dehydrogenase appears to be associated with a chronic progressive degenerative disorder manifesting parkinsonian extrapyramidal features, ataxia, supranuclear oculomotor dysfunction, a peripheral neuropathy and, in some cases, amyotrophy. The clinical features resemble those of the Dejerine-Thomas type of
olivopontocerebellar atrophy
. The data suggest autosomal dominant inheritance with low penetrance. Measurement of leukocyte
glutamate dehydrogenase
should be routinely performed in the evaluation of newly diagnosed or atypical cases of parkinsonism.
...
PMID:Glutamate dehydrogenase deficiency in patients with olivopontocerebellar atrophy. 668 27
1
2
Next >>